The Università degli Studi del Piemonte Orientale “Amedeo Avogadro is a university located in Alessandria, Novara and Vercelli, Italy. It was founded in 1998 and is organized in 7 faculties. Before 1998 the seven faculties were part of the University of Turin.

During the past decade, Universita del Piemonte Orientale conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universita del Piemonte Orientale" #1 sponsor was "Università degli Studi del Piemonte Orientale "Amedeo Avogadro"" with 3 trials, followed by "Celgene" with 2 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 2 trials sponsored, "German Breast Group" with 1 trials sponsored and "Skin Analytics Limited" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universita del Piemonte Orientale" #1 collaborator was "Università degli Studi del Piemonte Orientale "Amedeo Avogadro"" with 2 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "Azienda Ospedaliero Universitaria Maggiore della Carita" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator and "Centro Hospitalar De São João, E.P.E." with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Universita del Piemonte Orientale" are "B-Cell Chronic Lymphocytic Leukemia" (1 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Basal Cell Carcinoma" (1 trials), "Circulating Tumor Cell" (1 trials) and "Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Universita del Piemonte Orientale" in a lesser frequency.

Most popular intervention types in "Universita del Piemonte Orientale" are "Drug" (5 trials), "Behavioral" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lenalidomide" (2 trials), "Brief counseling based on the 5As model" (1 trials), "Capecitabine" (1 trials), "Carboplatin" (1 trials) and "Chlorambucil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universita del Piemonte Orientale" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Universita del Piemonte Orientale". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Universita del Piemonte Orientale, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universita del Piemonte Orientale, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".